Presentation is loading. Please wait.

Presentation is loading. Please wait.

Androgen receptor alterations and outcome.

Published byMilena Nowakowska Modified over 5 years ago

Similar presentations

Presentation on theme: "Androgen receptor alterations and outcome."— Presentation transcript:

1 Androgen receptor alterations and outcome.
Androgen receptor alterations and outcome. (A) AR splice variant landscape. LBD, ligand binding domain. (B) AR pathway expression score in AR-amplified (n = 168) versus nonamplified (n = 159) tumors. ***P < (C) AR amplification frequency in ARSI-naive versus exposed tumors. (D) Kaplan–Meier analysis showing time on treatment with a first-line ARSI in AR-amplified versus nonamplified tumors. (E) Association between ARV7 expression and time on treatment with a first-line ARSI. o, censored event; x, off-treatment event. Wassim Abida et al. PNAS 2019;116:23: ©2019 by National Academy of Sciences

Download ppt "Androgen receptor alterations and outcome."

Similar presentations

MDM2: Oncogene Chan Lee. Discovery of MDM2: starting with tumor suppressor p53.

MDM2: Oncogene Chan Lee. Discovery of MDM2: starting with tumor suppressor p53.
by Kevin J. Paavola, Harwin Sidik, J

by Kevin J. Paavola, Harwin Sidik, J
FasDR (CD95) in many cancers, in particular Non-Hodgkin’s Lymphoma Benjamin Badger.

FasDR (CD95) in many cancers, in particular Non-Hodgkin’s Lymphoma Benjamin Badger.
Cell Communication Part II

Cell Communication Part II
Comparison (θ) of the mean dinucleotide variability distribution for (A) genes with MAE vs. Comparison (θ) of the mean dinucleotide variability distribution.

Comparison (θ) of the mean dinucleotide variability distribution for (A) genes with MAE vs. Comparison (θ) of the mean dinucleotide variability distribution.
Comparison (R) of the mean observed to expected dinucleotide distribution for (A) genes with MAE vs. Comparison (R) of the mean observed to expected dinucleotide.

Comparison (R) of the mean observed to expected dinucleotide distribution for (A) genes with MAE vs. Comparison (R) of the mean observed to expected dinucleotide.
Balancing selection characterizes both MAE genes and cell type-specific genes (expressed in either nsc or asl but not in both). Balancing selection characterizes.

Balancing selection characterizes both MAE genes and cell type-specific genes (expressed in either nsc or asl but not in both). Balancing selection characterizes.
(A) Heat map showing expression changes during in vitro differentiation of nscs to astrocytes. (A) Heat map showing expression changes during in vitro.

(A) Heat map showing expression changes during in vitro differentiation of nscs to astrocytes. (A) Heat map showing expression changes during in vitro.
Empirical mutation-selection phase diagram of tumor evolution.

Empirical mutation-selection phase diagram of tumor evolution.
Schematic representation of possible effects of different factors on systemic resilience. Schematic representation of possible effects of different factors.

Schematic representation of possible effects of different factors on systemic resilience. Schematic representation of possible effects of different factors.
Altered cell migration factors and increased intestinal tumorigenesis in APC1638N/+ mice. Altered cell migration factors and increased intestinal tumorigenesis.

Altered cell migration factors and increased intestinal tumorigenesis in APC1638N/+ mice. Altered cell migration factors and increased intestinal tumorigenesis.
Behaviorally dependent allele-specific expression.

Behaviorally dependent allele-specific expression.
Empirical mutation-selection phase diagram of tumor evolution.

Empirical mutation-selection phase diagram of tumor evolution.
Decreased cell polarity and adhesion protein expression after 56Fe radiation. Decreased cell polarity and adhesion protein expression after 56Fe radiation.

Decreased cell polarity and adhesion protein expression after 56Fe radiation. Decreased cell polarity and adhesion protein expression after 56Fe radiation.
HDAC3, but not HDAC2 is in complex with tau protein.

HDAC3, but not HDAC2 is in complex with tau protein.
Structure-based ligand design toward a selective M3R antagonist.

Structure-based ligand design toward a selective M3R antagonist.
Principal component analysis of the GO category composition of all genes in each genome/transcriptome and WGD paralogs. Principal component analysis of.

Principal component analysis of the GO category composition of all genes in each genome/transcriptome and WGD paralogs. Principal component analysis of.
WCI evolve as organisms become more complex.

WCI evolve as organisms become more complex.
A model for dual inhibition of BCL2 and MCL1 to release BIM and induce apoptosis. A model for dual inhibition of BCL2 and MCL1 to release BIM and induce.

A model for dual inhibition of BCL2 and MCL1 to release BIM and induce apoptosis. A model for dual inhibition of BCL2 and MCL1 to release BIM and induce.
A Stepping Stone Toward Personalized Oncology: Genomic Analysis of Circulating Tumor Cells to Guide Management of Metastatic Castration-resistant Prostate.

A Stepping Stone Toward Personalized Oncology: Genomic Analysis of Circulating Tumor Cells to Guide Management of Metastatic Castration-resistant Prostate.

Similar presentations

Ads by Google